✨ Medicines Notices




30 OCTOBER NEW ZEALAND GAZETTE 3661

Health

Medicines Act 1981

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Bretylium tosylate 50 mg/mL in 10 mL Injection, vial and ampoule Abbott Laboratories, Rocky Mount, North Carolina, United States of America β€”

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 21st day of October 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of October 1997.

go7652

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Interferon beta-1a 30 mcg and water for injection 2 mL as diluent Powder for injection, vial; diluent, ampoule Ben Venue Laboratories Inc., Bedford, Ohio, United States of America; Delta West Pty Limited, Bentley, Western Australia, Australia (diluent only) Avonex

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 24th day of October 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go7772

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Warfarin sodium 1 mg, 2 mg, 5 mg Tablets The Boots Company PLC., Nottingham, United Kingdom Coumadin

Note: This consent is valid for 2 years from the 31st day of October 1997.

Dated this 24th day of October 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go7773



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1997, No 155


NZLII PDF NZ Gazette 1997, No 155





✨ LLM interpretation of page content

πŸ₯ Provisional Consent for Bretylium Tosylate

πŸ₯ Health & Social Welfare
21 October 1997
Medicines Act 1981, Provisional Consent, Bretylium Tosylate, Abbott Laboratories
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Provisional Consent for Interferon Beta-1a

πŸ₯ Health & Social Welfare
24 October 1997
Medicines Act 1981, Provisional Consent, Interferon Beta-1a, Avonex, Ben Venue Laboratories, Delta West Pty Limited
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Renewal of Provisional Consent for Warfarin Sodium

πŸ₯ Health & Social Welfare
24 October 1997
Medicines Act 1981, Provisional Consent Renewal, Warfarin Sodium, Coumadin, The Boots Company PLC
  • G. R. Boyd, Chief Advisor, Regulation and Safety